Cano Health reduced its workforce by 21% in Q3
The struggling primary care chain, which is still seeking a buyer, has exited from several state markets.
The struggling primary care chain, which is still seeking a buyer, has exited from several state markets.
The company has decided to exit the mapping and ablation business and focus its remaining cash on the Medtronic partnership.
Acutus laying off 65% of employees to focus solely on Medtronic heart device deal Read More »
The hospital operator said Thursday it is investing billions to expand emergency services and high acuity business lines.
HCA outlines plans to expand market share by 2030 Read More »
The company, facing pressure from regulators to divest Grail, also formed a special committee to speed decisions on the fate of the liquid biopsy test maker.
Illumina explores options for Grail, hires advisers Read More »
DePuy Spine will cease manufacturing at the site as the medtech giant restructures its strategy in the sector.
J&J orthopedics subsidiary undergoes layoffs at Colorado facility Read More »
The drugs shifting to preferred status — meaning they’ll be available for under $35 per month in out-of-pocket costs — were previously on tier three or excluded altogether from the pharmacy benefit manager’s formulary lists.
Optum Rx moves 8 insulins to preferred formulary status as pressure mounts on PBMs Read More »
The FDA is encouraging manufacturers to transition to traditional review pathways now that the acute phase of the COVID-19 crisis is over.
Acon receives first FDA clearance for over-the-counter COVID-19 antigen test Read More »
Introducción En un mundo empresarial cada vez más competitivo y en constante evolución, la eficiencia y la innovación en la gestión de procesos se han convertido en pilares fundamentales para el éxito. Aquí es donde SAP Signavio se …
SAP Signavio: Transformación de Procesos Empresariales Read More »
Durante siglos, los juegos de cartas se han destacado como una importante fuente de diversión y reto, siendo el Solitario uno de los más destacados y apreciados en este ámbito. Este juego, conocido por su simplicidad y complejidad inherente, atrae a personas de todas las edades. …
XNK Therapeutics AB announced that Johan Liwing, CEO, will present the company at the at Investival Showcase Meeting in London, on November 13th
XNK Therapeutics to present at Investival Showcase Meeting – November 10, 2023 Read More »